This panel will reflect on the future trade of THC products and how such trade can function without between countries, above and beyond the existing Single Convention. We see that besides Canada and Uruguay, other countries are on the starting blocks to fundamentally change their cannabis policies. Apart from the USA, next year’s change of cannabis policy could include Germany, as there are federal elections and a new government will be highly likely. Luxembourg has already decided on legalization and New Zealand is holding a referendum on it in November this year. Not in every case the local demand will be covered by local cultivation. Domestic cultivation is not even sensible from an environmental point of view, as too much energy is consumed in northern regions. In Germany alone, the demand for dried flowers from a legal and regulated export market is estimated with 500-600 tons. If new and modern products like Vape-Pens, Edibles and Beverages are developed, some countries and regions already have a know-how advantage which predestines them for the export of the products. This session will look at how an international supply chain for recreational cannabis products can be designed and how the enormous demand for products from legal markets can be satisfied. What conditions need to be created at the level of international law to make global trade possible? And what about import duties, safety standards and Intellectual Property?
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
|Changes in the scope of control of substances: proposed scheduling recommendations by the World Health Organization on cannabis and cannabis-related substances Note by the Secretariat (409.9 KB)||Available after Purchase|
|Commission on Narcotic Drugs, 62nd session Questions to INCB in preparation of the 5th Intersessional Meeting on 23 September 20191 submitted by 19 August 2019 Statement by Stefano Berterame, (289.7 KB)||Available after Purchase|
|Management of substance abuse (153 KB)||Available after Purchase|
Kai has been a business and corporate lawyer in Germany for almost 17 years gaining wide range of experiences in the process. He is very familiar with the interconnectivity between national and European regulations, especially in regard to consumer protection, product safety and emerging new cannabis products. He has engaged in advocacy relating to cannabis beginning in early stages of his studies at Philipps University Marburg when the German Supreme Court ruled that small amounts of cannabis should not be criminalized. After medical cannabis was legalized in Germany, Kai started a legal blog (canna-biz.legal) on all the relevant new developments in the emerging cannabis market and became a legal expert especially for CBD products.
He regularly speaks at international cannabis conferences on topics of the German and European legal framework. Lastly he spoke at the ICBC Virtual Global Symposium in June 2020, at the First Asian Hemp Summit 2019 in Hong Kong and at the Cannabis Law Institute 2019 in New York. He has published articles on the Prohibition Partners platform and was cited by the Cannabis Law Report as well as the Canadian Globe and Mail. Kai co-founded the International Cannabis Bar Association which with an event in Berlin in April 2019. He consults major CBD and medical cannabis companies as well as a reputable online knowledge portal for medical cannabis and CBD.
Kai is member of the European Hemp Association (EIHA), the German Hemp Association (DHV), Law Enforcement Against Prohibition (LEAP Germany), and Advisory Board Member of the International Cannabis Bar Association (INCBA).
Areas of Law:
born in 1972 in Löhne/Westf., Germany
studied law at the universities of Marburg, Adelaide (Australia), Cologne, and Berlin, first and second state exam (law degree)
worked as a legal expert at the press center of the German Federal Diet, worked for the Berlin District Court, for the Director of Public Prosecution in Berlin, for the Office for the Protection of the Constitution in Berlin and the Hong Kong Consulate General
www.canna-biz.legal (the legal cannabis blog)
Jason Moscovici is a partner, lawyer and biochemist with ROBIC, LLP, a multidisciplinary intellectual property law firm from Quebec, Canada. His IP practice specializes in regulated industries such as food, alcohol, cannabis, pharmaceuticals, medical devices, cosmetics, natural health products, advertising and consumer products.
Jason’s focus on the valorization and enforcement of intellectual property, as well as the numerous compliance issues that orbit regulated industries, have allowed him to quickly become one of the most trusted legal advisors to the emerging cannabis industry. His perspectives on compliance, intellectual property and the commercial hurdles related specifically to cannabis are routinely solicited by stakeholders in this space.
Jason leads ROBIC`s cannabis group and sits on the life sciences committee of the firm.
Simon is the founder of Innovation Liberation Front.
Before starting Innovation Liberation Front, Simon practiced for seventeen years as a lawyer and patent attorney, spending 9 years as the partner heading the Commercialisation Team of James & Wells Intellectual Property. Much of his work involved licensing intellectual property internationally.
In 2018, 2017, 2016 and 2012 Simon was listed in Intangible Asset Management magazine’s IAM Strategy 300 – the World’s Leading IP Strategists and IAM Patent 1000 – Guide to the World’s Leading Patent Practitioners.
Simon is well versed in the needs of entrepreneurial growth companies, and has been himself involved as a co-founder or investor and advisor in several startups. These include Magic Mitten Limited, which invented the product now marketed as GroHush by The Gro Company in 30 countries around the world; Nutrient Rescue, which manufactures and markets nutritional plant powders; Ligar LP, which develops molecularly imprinted polymers for specific extraction needs; and Sagitto, which provides data science as a service based on handheld NIR scanners to characterise oils, textiles, plastics and other substances.
Mr. Walsh has testified before Congress and published extensively on the need to reassess drug policy goals, strategies, and indicators. His analyses have underscored the limits of supply-oriented drug policies and the extensive damage they cause. Connecting domestic U.S. reforms to the international drug policy debate, Walsh has worked extensively on the question of Drug Treaties with relation to cannabis legalization, co-authoring the report “Cannabis Regulation and the UN Drug Treaties: Strategies for Reform”. Mr. Walsh similarly co-authored “Marijuana Legalization is an Opportunity to Modernize International Drug Treaties,” arguing that policy shifts underway in the Americas open the door to modernizing the global drug control regime. His work has contributed to the expansion of the international drug policy reform debate, and been instrumental in convening reform advocates and practitioners from across the hemisphere to discuss design and evaluation of legal, regulated cannabis.
Mr. Walsh also follows broader political developments in the Andean region, with particular emphasis on Venezuela. He tracks democracy and human rights issues in the country, and has established WOLA as a leading voice advocating for reasoned, respectful U.S. hemispheric relations. Mindful of the polarized politics in the region and the similarly polarized and sensationalized accounts that have marked U.S. views of developments in the Andes, Mr. Walsh has provided a balanced perspective, and WOLA has provided a venue for impassioned but respectful debate.
A frequent commentator on drug policy developments in the U.S. and Latin America, Mr. Walsh has been quoted in The New York Times, The Washington Post, The Wall Street Journal, The Associated Press, National Public Radio, and numerous television and international news outlets. In addition to his congressional testimony, publications, press appearances, Mr. Walsh has organized and spoken at numerous U.S. and international conferences. Prior to joining WOLA, he served as director of research at Drug Strategies and worked at the Center of Concern on the “Rethinking Bretton Woods Project,” an effort to forge consensus on ideas for reform of the World Bank, the International Monetary Fund, and international trade arrangements.
He received a B.A. in Theology from Georgetown University (1986) and an M.A. in Public Policy from the Johns Hopkins University (1997).
Daniel is a lawyer with more than fifteen years of experience. Actually he is partner at Estudio Podestá, law firm founded in 1978.
Since 2013, he has specialized in law framework of hemp and cannabis industries in Uruguay, advising companies throughout the process of obtaining the various authorizations before public authorities and counselling them in corporate matters and M&A.
On October 2018 Daniel was appointed as general secretary of the Chamber of Medicinal Cannabis Companies for the period 2018-2021.
Daniel has written articles about law framework for the hemp and cannabis industry in Uruguay and LATAM and has been speaker in international conferences.
Global Perspectives of Legalization
Original Program Date: 10/13/2020 - SKU INCBA101320GL
Defining Access: Medical, Adult, OTC, or Something Else?
Original Program Date: 10/13/2020 - SKU INCBA101320DE
Import / Export: The Cross Border Hemp Trade
Original Program Date: 10/15/2020 - SKU INCBA101520IM
Please wait ...